BB Pureos Bioventures logo

BB Pureos Bioventures

Venture Capital

Pureos is a venture capital fund investing in private innovative drug development companies

Switzerland Pfaffikon, Switzerland 14 employees Biotechnology

10

Total Investments

5

Portfolio Companies

-

Exits

1

Industries

General Information

Industries Biotechnology

Company Overview

Employees 14
Location Switzerland Pfaffikon, Switzerland
Website pureosbio.com

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About BB Pureos Bioventures

Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Recent Investments (10)

View All
Company Stage Amount Date
Series A •••••• Oct 2025
Series D •••••• Nov 2024
Seed •••••• Jun 2024
Series C •••••• Apr 2023
Series A •••••• Apr 2023
Portfolio company •••• ••••
Series A •••••• Jun 2022
Portfolio company •••• ••••
Spinout •••••• May 2022
Portfolio company •••• ••••
Series B •••••• Jun 2021
Portfolio company •••• ••••
Spinout •••••• Apr 2019
Portfolio company •••• ••••
Series A •••••• Mar 2019

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes